(Press-News.org) A new fund to fast-track patient access to potentially valuable new medicines may incentivise the pharmaceutical industry to develop high priced drugs for rare diseases with weak evidence on clinical benefits.
Health economics and policy academics from the London School of Hygiene & Tropical Medicine (LSHTM), writing in the Journal of the Royal Society of Medicine, warn that if the NHS England Innovative Medicines Fund (IMF) is not implemented appropriately, it risks disincentivising the generation of essential evidence and could shift the financial burden from the pharmaceutical industry to the public finances.
The IMF operates on similar terms to the Cancer Drugs Fund (CDF), with a fixed annual budget of £340 million, equal to the CDF. Lead author Dr Aris Angelis, Assistant Professor in Health Economics at the Department of Health Services Research and Policy at LSHTM, said: “While we are broadly supportive of the eight guiding principles of the IMF, we believe their operationalisation is described in insufficient detail and without fully leveraging the CDF experience.”
The authors say the value of the CDF to society remains unproven, with concerns about lack of transparency in the cost of drugs and the time period during which they remain under the CDF scheme.
The authors also question why the CDF and IMF schemes, also known as ‘managed access’ schemes, should only exist for medicines and no other types of interventions. “The need to consider non-medical interventions is particularly relevant in disease areas such as cancer, for which access to high quality radiation and surgical treatment are critical to improving outcomes,” said co-author Dr Ajay Aggarwal, Associate Professor at LSHTM and clinical oncologist.
Another concern the authors highlight is the entry criteria for the ‘most promising’ medicines into the IMF, which, they say, ‘are currently critically lacking in detail.’
If the IMF is to successfully foster early access to clinically effective, safe and cost-effective medicines, say the authors, its operational details and mechanisms in place need to be carefully designed.
Dr Angelis explained: “The IMF, like the CDF, should be an exceptional route to patient access while providing the requisite evidence, mainly from randomised controlled trials, for reducing uncertainty about a drug’s clinical and cost-effectiveness.”
The authors also say the notion of opportunity cost must not be ignored. “IMF funding could always be used for other health services and technologies with strong evidence on effectiveness and value-for-money which could improve overall population health,” said Andrew Briggs, Professor of Health Economics at LSHTM.
END
New ‘promising medicines’ fund may incentivise commercialisation of high price drugs with weak evidence on clinical benefits
2023-08-25
ELSE PRESS RELEASES FROM THIS DATE:
Certain gut conditions may be early warning signs of Parkinson’s disease
2023-08-25
Certain gut problems, such as constipation, difficulty swallowing, and irritable bowel syndrome (IBS), may be early warning signs of the neurological condition Parkinson’s disease, suggests research published online in the journal Gut.
Gastrointestinal symptoms are thought to precede the development of cerebrovascular disease, such as stroke or a brain aneurysm, or Alzheimer’s disease, and it has been suggested (Braak’s hypothesis) that gut conditions may precede the development of Parkinson’s disease too.
To ...
Poor lifestyle of over 60s linked to heightened risk of nursing home care
2023-08-25
Over 60s with the unhealthiest lifestyles are significantly more likely to require admission to a nursing home than their peers with the healthiest lifestyles, suggest the findings of a large population study published online in the Journal of Epidemiology & Community Health.
Physical inactivity, smoking, poor diet and sleep disorders between the ages of 60 and 64 seemed to be particularly influential: they were associated with a more than doubling in the risk of admission, the findings show.
Modifiable lifestyle risk factors are associated with the development and progression of several long term conditions, ...
Beverage Plant Research indexed in CABI
2023-08-25
We are delighted to announce that the Beverage Plant Research articles are now indexed in CABI specialized databases. This important milestone ensures that articles published in Beverage Plant Research are easily found when searching for beverage plant literature and it enables this journal authors to keep track of how often their article has been cited by others. According to the correspondence made by CABI, the Beverage Plant Research will be indexed from Volume 1, 2021.
About Beverage Plant Research
Beverage Plant Research (e-ISSN: ...
Paper drinking straws may be harmful and may not be better for the environment than plastic versions, researchers warn
2023-08-25
“Eco-friendly” paper drinking straws contain long-lasting and potentially toxic chemicals, a new study has concluded.
In the first analysis of its kind in Europe, and only the second in the world, Belgian researchers tested 39 brands of straws for the group of synthetic chemicals known as poly- and perfluoroalkyl substances (PFAS).
PFAS were found in the majority of the straws tested and were most common in those made from paper and bamboo, the study, published ...
Sediment movement during Hurricane Harvey could negatively impact future flooding, prove costly to Houston, UH study finds
2023-08-25
Enormous amounts of sediment, or sand and mud, flowed through Houston waterways during Hurricane Harvey in 2017, due in part to modifications made by humans to bayous, rivers and streams over the past century, that could seriously impact future flooding events and be costly to the City of Houston.
New analysis by geology researchers at the University of Houston found 27 million cubic meters of sediment, or 16 Astrodomes, moved through 12 Houston waterways and Addicks and Barker reservoirs during Harvey, the largest rainfall event in U.S. history. After the storm, up to five feet ...
USC-supported startup receives major grant for clinical trial of a promising eye treatment
2023-08-24
A stem cell patch developed by USC researchers for patients with macular degeneration will soon be tested in a phase 2b clinical trial.
This latest milestone in the patch’s development was made possible by a combined $21 million in support from a state organization, a nonprofit foundation and the university. Last month, the California Institute for Regenerative Medicine (CIRM) awarded an estimated $12.4 million to the USC-supported startup Regenerative Patch Technologies (RPT) to test the safety and efficacy ...
New detector paves the way to large-scale optical neural networks
2023-08-24
For the first time, researchers have used a surface normal nonlinear photodetector (SNPD) to improve the speed and energy efficiency of a diffractive optical neural network (ONN). The new device lays the groundwork for large-scale ONNs, which can perform high-speed processing at the speed of light in an extremely energy efficient manner.
Farshid Ashtiani from Nokia Bell Labs will present this research at Frontiers in Optics + Laser Science (FiO LS), which will be held 9 – 12 October 2023 at the Greater Tacoma Convention ...
The right combo: Getting the most health benefits from fruit smoothies
2023-08-24
Smoothies can be a tasty and convenient way to get the important fruits and vegetables you need for a healthy diet. But is a banana and blueberry smoothie the best combo? Researchers at the University of California, Davis, suggest that blending certain ingredients in smoothies can influence whether your body is getting a nutritional boost.
The study, published today in the Royal Society of Chemistry’s journal Food and Function, used smoothies to test how various levels of polyphenol oxidase, an enzyme in many fruits and vegetables, affects the levels of flavanols in food to be absorbed by the body. Flavanols ...
$12 million grant funds foundational research on early liver transplantation
2023-08-24
Alcohol-associated liver disease accounts for 50% of liver-related deaths, and its rates are rising worldwide. But one of the best treatment options, early liver transplantation (ELT)—transplants done with no mandatory period of abstinence from alcohol—is also one of the most controversial, partly because of concerns that patients will relapse to alcohol after transplantation.
Part of the problem is that livers for transplants are in short supply, and researchers lack data to determine who will benefit most from ELT. Studies show that decisions about who gets a transplant can, at times, be influenced by bias or unsystematic. ...
Study shows technology boosts public health programs
2023-08-24
An examination of the SCALE-UP Counts program was recently published in the journal Pediatrics. This analysis, led by Yelena Wu, PhD, investigator at Huntsman Cancer Institute and associate professor in the department of dermatology at the University of Utah (the U), and David Wetter, PhD, MS, investigator at Huntsman Cancer Institute and professor in the department of population health sciences at the U, received support from RADx-Underserved Populations (RADx-UP) and funding from the National Institute of Health (NIH).
The SCALE-UP Counts program was designed to promote COVID-19 testing through collaboration ...